As part of the Collaborate to Innovate cohort programme, we are organising a networking event on the 19th of January, at the etc.venues County Hall.
Collaborate to Innovate (C2N) is MedCity's flagship strategic programme to catalyse partnerships between industry and academia with common goals. These partnerships enable transfer of cross-sector knowledge across the life sciences ecosystem, supporting validation and commercialisation of the most promising Life Science innovations.
More information about the programme:
London Diagnostics (LDx) marks the fifth and latest C2N programme, funded by LEAP, enabling fast-tracked, funded collaborative R&D projects/commercial mentorship opportunities for selected London based Diagnostic SMEs that help validate and bring their products/technologies to market.
The event celebrates Collaborate to Innovate by bringing together and providing collaborative partnering opportunities with SMEs from four of the C2N cohorts:
• Advanced Therapies (x2)
• Stroke Therapies
This event will not only be an excellent setting to meet with the companies involved, but also to meet with their academic collaborators, as well as non-profit organisations, charities, investors and professional service providers by way of MedCity's extended network.
The event will be in-person and will incorporate a general networking area alongside partitioned areas for speed partnering meetings with the companies that comprise the four C2N cohorts.
Each attendee will have four minutes at one of the C2N Companies tables, after which a bell will be sounded and the attendee will require to move on to the next company table, until a circuit is complete.
The event will run between 13:00 and 18:00, with speed networking sessions commencing from 14:00.
Refreshments will be provided throughout the afternoon, followed by drinks served towards the end of the event.
Copyright © 2023 Stevenage Bioscience Catalyst